In the healthy human being, there are a variety of intrinsic defense mechanisms that control the number of bacteria and its composition in various parts of the gastrointestinal tract. Additionally, probiotics, herbals, and certain diets may also play a significant role in the treatment of SIBO in the future. The underlying principles of treatment of SIBO are complex and typically treated with a course of antibiotics as first line therapy along with addressing the underlying defect.
#Bacterial overgrowth syndrome trial
A third approach is the empiric treatment in patients with suspected SIBO with a trial of antibiotics with subsequent evaluation of symptomatic response and normalization of breath testing. Non-invasive, indirect methods include hydrogen and methane breath testing (using either glucose or lactulose as a substrate). The gold standard for diagnosis remains microbial investigation of jejunal aspirate. Although the diagnosis of SIBO is complex, there are a few different approaches that may be used to help establish the diagnosis in patients with suspected SIBO. For this reason, the diagnosis may often be overlooked. The clinical features of SIBO are widely variable, including abdominal bloating, nausea, abdominal pain, chronic diarrhea, flatulence and weight loss however, some patients have only subtle symptoms. The etiology of SIBO is presumably multiefactorial and complex, including alternation of gastric acid secretion (primarily in the form of achlorhydria and pancreatic and biliary secretions insufficiency), chronic disease (e.g.renal failure, liver cirrhosis) and old age are among some of the different causes that result in competition between the host and overgrown bacteria for the ingested nutrients and catabolism of these nutrients which subsequently lead to release of toxic metabolites causing variable degree of injury to the proximal intestinal cells. Any disturbance or alteration in the inherent defense mechanisms can lead to small intestinal bacterial overgrowth (SIBO) therefore, we can define SIBO as an increase in the number and/or an alteration in the type of bacteria found in the small bowel. These defense mechanism include gastric acid secretion, preserved gastrointestinal motility (particularly phase III of the migrating motor complex), normal bacterial microflora, pancreatic biliary secretion, and an intact ileocecal valve, all of which protect against bacterial overgrowth.
0 kommentar(er)
